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Objective: The intracranial pressure-volume relation contains information relevant for 
diagnostics of hydrocephalus and other space occupying pathologies. We aimed to 
design a noise-resilient surrogate for this relationship that can be calculated from 
intracranial pressure (ICP) signals. 
 
Approach: The new surrogate, termed respiratory amplitude quotient (RAQ), 
characterizes the modulation of the cardiac pulse wave amplitude by the respiratory 
wave in the ICP time course. RAQ is defined as the ratio of the amplitude of the 
respiratory wave in the ICP signal to the amplitude of the respiration-induced variation 
in the course of the cardiac pulse wave amplitude. We validated the calculation of RAQ 
on synthetically generated ICP waveforms. We further extracted RAQ retrospectively 
from overnight ICP recordings in a cohort of hydrocephalus patients with aqueductal 
stenosis, age 55.8  18.0 years, and a comparison group with hydrocephalus diagnosed 
by morphology in MRI, but not responsive to either external lumbar drainage or 
ventriculo-peritoneal shunting, age 72.5  6.1 years. RAQ was determined for the full 
recordings, and separately for periods containing B-waves. 
 
Main results: We found a mean difference of less than 2 % between the calculated 
values of RAQ and the theoretically determined equivalent descriptors of the synthetic 
ICP waveforms. In the overnight recordings, we found significantly different RAQ 
values during B-waves in the aqueductal stenosis (0.86 ± 0.11) and non-responsive 
hydrocephalus patient groups (1.07 ± 0.20), p=0.027. In contrast, there was no 
significant difference in other tested parameters, namely pressure volume index, 
elastance coefficient, and resistance to outflow. Neither did we find significant 
difference when considering RAQ over the full recordings. 
 
Significance: Our results indicate that RAQ may function as a potential surrogate for 
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Proper function of the central nervous system (CNS) is dependent on pressure homeostasis 
within the cranial and spinal compartments. Due to limited available space, intracranial 
pressure (ICP) is tightly coupled to changes in the volumes of cerebrospinal fluid (CSF), 
blood and interstitial fluid (ISF). This pressure-volume relationship is influenced by various 
factors, including space-occupying pathologies such as hydrocephalus. Consequently, the ICP 
signal contains information on the biomechanical state of the CNS. 
 
The pressure-volume relationship can be derived with methods that rely on volume loading, 
as well as using approaches based on the analysis of temporal variations of ICP. Whereas the 
former are more invasive and carry a higher risk of infection, the latter are influenced by 
modulations of ICP that do not reflect changes in the pressure-volume relationship. Herein, 
we present a surrogate that does not rely on volume loading and that is influenced to a 
considerably smaller degree by ICP changes not originating in the pressure-volume 
relationship.  
 
Since the first ICP monitoring in 1959 by Lundberg [1], a number of metrics linking 
biomechanical changes reflective of craniospinal pathophysiology to the ICP signal have been 
developed. Marmarou defined the pressure volume index (PVI) as the increase in craniospinal 
volume needed to elevate ICP to ten times the baseline level [2], [3]. Provided that the 
pressure-volume curve has the expected exponential form, PVI is constant and fully describes 
the curve in conjunction with an anchor point, e.g., with volume change defined as zero at 
baseline ICP.  
Avezaat and Eijndhoven [4] showed that PVI can also be determined by a constant infusion 
volume loading technique. Furthermore, they extended the original exponential pressure-
volume relation with a constant term: 𝐼𝐶𝑃 =  𝐼𝐶𝑃0 + 𝐼𝐶𝑃1 ∙  𝑒𝑘 ∙𝑉  (1) 
 
Here, ICP0 and ICP1 are constant pressure terms, k is the elastance coefficient, and V is the 
change in craniospinal volume with respect to equilibrium.  
Next to PVI, volume loading gives access to further metrics that describe the pressure-volume 
relation. Maramarou et al. defined the resistance to outflow (RO) as the resistance needed to 
maintain a certain pressure plateau above the resting ICP [3]. While RO can be calculated 
from a single bolus injection or from constant volume infusions, differences in the values 
obtained with these methods have been observed. These may be attributed, in part, to 
viscoelastic properties of the CNS and its surroundings [5]. 
Procedures based on volume loading are time consuming and carry the risk of infection. 
These disadvantages have to be weighed against a possible diagnostic value. For idiopathic 
normal pressure hydrocephalus, evaluation of the response to lumbar drainage is a guideline 
recommendation in [6], whereas the assessment of RO is described as optional and no further 
methods requiring volume loading are advocated. For severe traumatic brain injury, even with 
concomitant increase in ICP and danger of cerebral herniation, diagnostics based on volume 
loading are not even mentioned in the current guidelines [7]. 
While volume loading provides well-interpretable quantitative data on the craniospinal 
pressure-volume relation, the ICP signal in itself also carries substantial information. 
Lundberg referred to waveforms in the ICP time course as cardiac pulse waves (origin in 
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cardiovascular action), respiratory waves (induced by effects of respiration), and A-, B- and 
C-waves. The frequency, duration, and magnitude of B-waves have been considered for use in 
hydrocephalus diagnostics [8], but are currently not part of any standardized diagnostic 
regime.  
Hu et al. described an algorithm for extracting the amplitudes and positions of sub-
components of the cardiac pulse waveform [9]. Phenomenologically, these sub-components 
are indicative of the pressure-volume relationship and/or the compliance as also described by 
Kiefer et al. [10]. Associations with other parameters and diagnoses were described as well 
[11], [12]. The method was also used to characterise cerebral vascular changes during acute 
ICP drop in SAH [13], [14]. However, it has not found widespread entry into clinical routine 
so far. Price et al. first described the metric RAP, regression coefficient of the 
amplitude/pressure characteristic [15], which Czosnyka et al. later redefined as follows: “The 
rate of increasing amplitude per rise in ICP is called AMP/P slope, where P represents 
pressure“ [16]. Lenfeldt et al. introduced the parameter RPPC as the slope (k) of the linear 
regression equation Δp = k ·  pmean + m , where Δp is the amplitude of each individual cardiac 
pulse wave, pmean the mean ICP during that cardiac pulse wave, and m the y-intercept of the 
linear regression curve [17]. Furthermore, a parameter also called RAP was described as "the 
moving correlation coefficient between mean ICP and associated changes in pulse amplitude" 
[18]. 
All current parameters derived from the ICP signal have one thing in common: They are 
influenced by changes in ICP not caused by changes in the pressure-volume relationship. For 
instance, a patient’s transient shift in body position may change ICP in a fashion similar to the 
occurrence of a B-wave. Consequently, both will influence pressure-volume parameters 
derived from ICP similarly, even though the former does not reflect a pathologic change 
whereas the latter might. This explains, at least in part, why current methods that rely solely 
on pressure recordings and that do not require volume loading have not had a substantial 
clinical impact. 
As a step towards improving this situation, we describe herein a new surrogate termed 
respiratory amplitude quotient (RAQ) that does not rely on volume loading and that is 
affected to a lesser degree by changes in ICP that are not reflective of an altered pressure-
volume relation. Therefore, RAQ can be derived from ICP signals with only partial 
calibration. We further present an algorithm for computing RAQ and its application for 
possible discrimination of two patient groups with different types of hydrocephalus. 
 
2. Methods  
2.1 Calculation of RAQ 
 
We take advantage of the fact that in the ICP signal, the amplitude of the cardiac pulse wave 
varies periodically with the respiratory wave. When ICP rises in the expiratory phase of 
spontaneous respiration, the cardiac pulse wave amplitude increases. Conversely, it decreases 
with falling ICP in the inspiratory phase. For the definition of RAQ, we assume that 
respiration-induced changes in ICP follow the pressure-volume curve, and that the shape of 
the curve stays constant during respiratory and cardiac cycles. 
 
RAQ quantifies the change in the amplitude of the cardiac pulse component with the time 
course of the respiratory component in the ICP signal. We define RAQ as the ratio of the 
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amplitude of the respiratory wave to the amplitude of the respiration-induced variation in the 
course of the cardiac pulse wave amplitude,  
 𝑅𝐴𝑄 =  𝐴𝑟𝑝𝐴𝐴𝑣𝑝   (2) 
 
The individual parts of Equation 3 are illustrated in Figs. 1 - 4 using a synthetic ICP time 
course consisting of two sinusoidal components, one representing the cardiac pulse wave and 
the other the respiratory wave: ICP (black line) is drawn over ten cardiac cycles. The mean 
ICP calculated over each cardiac half-period (MICP, blue line) as well as the peak-to-valley 
and valley-to-peak cardiac pulse wave amplitude for each half period (Avp, orange line) are 
also shown. The peak-to-valley amplitude of the respiratory wave in the MICP curve (Arp) 
reflects the level of mean ICP change with respiration, while the peak-to-valley amplitude of 
the respiratory wave of the Avp curve (AAvp) reflects the level of cardiac pulse wave 




Fig. 1a. Illustration of the calculation of 
MICP, the mean ICP determined over each 
cardiac half-period. A synthetic ICP time 
course (black line) consisting of two 
sinusoidal components representing cardiac 
pulse and respiratory waves, respectively, is 
shown. The first MICP value, MICP1, is 
determined from the first peak of the ICP (pp1) 
to its first valley (pv1). 
Fig. 1b. Calculation of Arp, the amplitude of the 
respiratory wave in the MICP curve (blue line). To 
establish MICP, MICP1 is plotted for the duration of 
the first cardiac half-period. Then, the mean 
pressures are continuously determined for each half-
period from peak-to-valley and valley-to-peak, 
respectively, yielding the respective new value of 
MICP. The respiratory amplitude Arp is 
subsequently determined from the MICP curve as 
the highest amplitude in the respiratory frequency 
range (see Fig. 3).  
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Fig. 2a. Illustration of the calculation of Avp, 
the cardiac pulse wave amplitude for each 
half-period of the ICP time course (black 
line). The cardiac pulse wave amplitude of the 
first half period is determined from the first 
peak (pp1) to the first valley (pv1) as  
Avp1 = pp1 - pv1. 
Fig. 2b. Calculation of AAvp, the amplitude of the 
respiratory wave of the Avp curve (orange line). To 
establish AAvp, Avp1 is plotted for the duration of the 
first cardiac half-period. Then the cardiac pulse 
wave amplitudes are continuously determined for 
each half-period from peak-to-valley and valley-to-
peak, respectively. The respiratory amplitude AAvp 
is subsequently determined from the Avp time 
course as the highest amplitude in the respiratory 
frequency range (see Fig. 4). 
 
For the calculation of RAQ, pulse amplitudes have to be determined. We use the automatic 
multiscale-based peak detection algorithm (AMPD) for this purpose [19]. AMPD finds the 
systolic and diastolic points of the ICP signal in the time domain. We then calculate the peak-
to-valley and valley-to-peak cardiac pulse wave amplitudes for each half-period and form a 
time series consisting of those. We further calculate for each half-period the mean ICP and 
again form a time series. To determine the respiratory amplitudes of mean ICP and cardiac 
pulse amplitude courses, we apply fast Fourier transform (FFT) [20] on both time series, 
calculate the amplitude spectra, and then select the highest amplitude within the respiratory 
frequency range as shown in Figs. 3 and 4. We found that determining the amplitudes of the 
respiratory waves in the course of mean ICP and cardiac pulse amplitude was more reliably 
done in the frequency domain than in the time domain. A pseudocode describing a reference 
approach for calculating RAQ is shown in List 1 in Appendix I. The code is derived from a 
Matlab (The MathWorks, Inc., Natick, MA, USA) implementation that we used for the 
calculation of the RAQ values presented herein. 
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Fig. 3. Amplitude spectrum of the MICP signal shown in Figure 1b. Arp is determined as the highest peak in 
the respiratory frequency range (0.166 to 0.33 Hz). 
 
 
Fig. 4. Amplitude spectrum of the Avp signal shown in Figure 2b. AAvp is determined as the highest peak in the 
respiratory frequency range (0.166 to 0.33 Hz). 
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2.2 Numerical simulations 
 
To characterize RAQ under idealized conditions and to validate our Matlab program used to 
calculate RAQ in ICP recordings, we produced synthetic ICP time series by employing Eq. 
(1) and prescribing sinusoidal volume changes, Vp, in the cardiac pulse frequency range, fp, 
and sinusoidal volume changes, Vr, in the respiratory frequency range, fr:  
 𝐼𝐶𝑃 =  𝐼𝐶𝑃0 + 𝐼𝐶𝑃1 ∙  𝑒𝑘 ∙(𝑉𝑝+𝑉𝑟), (3) 
 
where  
 𝑉𝑝 =  𝑉𝑝2  ∙ sin(𝑡 ∙  𝑓𝑝  ∙ 2 ∙  𝜋) (4) 
 
and 
 𝑉𝑟 =  𝑉𝑟2  ∙ sin(𝑡 ∙  𝑓𝑟  ∙ 2 ∙  𝜋) (5) 
 
Here, Vp is the craniospinal volume change induced by cardiovascular action during each 
cardiac cycle, and Vr is the craniospinal volume change due to respiration during each 
respiratory cycle. The courses of two exemplary synthetic ICP curves over 30 seconds are 
shown in Fig. 5. The black curve in Fig. 5 reflects the output of a system described by Eq. 3 
with k=0.1/ml, which is indicative of a normal pressure-volume relationship. The orange 
curve with k=0.15/ml reflects a system with reduced overall compliance. Both the cardiac 
pulse wave amplitude and the respiratory amplitude of ICP are higher with k=0.15/ml. The 
modulation of the cardiac pulse wave amplitude by respiration is clearly visible. Whether or 
not the modulation of the cardiac pulse wave amplitude is "stronger" with k=0.15/ml cannot 
be determined visually, but - as we will show - can be quantified with RAQ. We calculated 
RAQ numerically using a time window of 6000 seconds and compared the values obtained to 
those representative of the system used to generate the ICP curves in the first place. 
 
To test whether the algorithm is resilient to a very common type of disturbance that does not 
have an influence on compliance, we furthermore produced synthetic ICP time series, again 
6000 seconds long, that feature pressure steps of 1, 2, and 3 mmHg at the 3000 second mark 
(see Fig. 6).  Typically, such pressure steps occur when the head elevation is changed during 
ICP recording. A 1 mmHg increase in ICP corresponds to a decrease in head elevation with 
respect to heart level by about 1.4 cm (not accounting for potential concomitant changes in 








Fig. 5. Synthetic ICP signals consisting of cardiac pulse waves and respiration-induced waves that are idealized 
as sine-shaped. Black line: k = 0.1/ml, orange line: k = 0.15/ml (for better discernibility drawn with an offset of 
ICP0 = 1 mmHg). The cardiac pulse waves (produced by cardiovascular action) and the respiration-induced 
waves are clearly discernible. The cardiac pulse wave amplitude is visibly larger at the peak of the respiration-








Fig. 6. Synthetic ICP signal with pressure step of 1 mmHg at 3000 s. 
 
2.3 Patient selection 
 
To assess a possible clinical application, we evaluated RAQ retrospectively in 
intraparenchymal ICP signals recorded with a sampling rate of 50 Hz overnight in two groups 
of patients with different aetiology of hydrocephalus. The study was approved by the local 
ethics committee (Ethikkommission Universität Leipzig, Az 014-13-28012013), and written 
informed consent was obtained from the patients.  
The first group, hereinafter referred to as AQS, consisted of 6 hydrocephalus patients with 
aqueductal stenosis diagnosed by magnetic resonance imaging (MRI), 55.8  18.0 years of 
age (mean and standard deviation), 4 males, 2 females. The second group consisted of 17 
hydrocephalus patients diagnosed by morphology with MRI who were non-responsive to 
external lumbar drainage or ventriculo-peritoneal shunting (non-normal pressure 
hydrocephalus, NNPH), age 72.5  6.1 years, 8 males, 9 females. In the AQS group, 
concurrent neurological and metabolic diseases were ruled out; the aqueductal stenosis was 
the only evident cause of hydrocephalus. These patients responded to CSF diversion surgery. 
The two groups were chosen to represent both cases with (AQS) and without (NNPH) 
obvious impairment of CSF circulation. 
2.4 Data analysis 
 
We determined RAQ after upsampling the ICP time series to 100 Hz. First, we calculated 
RAQ over the full recording period (RAQC). Because the pressure-volume characteristic is 
influenced by the occurrence of slow vasogenic waves (B-waves), we further calculated RAQ 
for periods containing such waves.  
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To identify B-wave containing periods, we applied the method described in [21]. Briefly, the 
ICP signal is compared to a set of B-wave templates and, using the cross-correlation function, 
the similarity of the ICP signal to the templates is quantified. For each recording, we 
calculated the following parameters that describe the power and occurrence of B-waves as 
described in [21]: ICPS, the root mean square amplitude of the B-waves, averaged over the B-
wave containing time; TFS, the time fraction of the total recording containing B-waves; and 
ICPSmean = ICPS ∙ TFS . After computing the RAQs of all B-wave containing periods, we 
calculated their mean value, RAQB. 
 
2.5 Statistical Analysis 
 
Anderson-Darling tests indicated that some parameters were not normally distributed. 
Therefore, we used two-sided Mann-Whitney U tests to identify statistical differences 
between the two patient groups (AQS and NNPH) for each parameter. The significance level 




3.1 Influence of k, Vp, Vr , depth of respiration and zero point and span errors on 
RAQ 
 
To characterize RAQ under changing physiological conditions, we varied the coefficient k in 
the exponent of the pressure-volume relation, the craniospinal volume change induced by 
cardiovascular action during each cardiac cycle, Vp, as well as the craniospinal volume 
change during each respiratory cycle due to respiration, Vr. Figure 7 shows RAQ as a 
function of k and, additionally, as a function of PVI, since the latter is more commonly used 
in the clinical setting. It is evident that RAQ is linearly dependent on PVI. Furthermore, Vp 
strongly influences RAQ, as is clearly visible in Fig. 8. Finally, Figure 9 shows that RAQ 
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Fig. 8. RAQ as a function of Vp, the craniospinal volume change due to cardiac action within each cardiac 
cycle, and k.  
 
 
Fig. 9. RAQ as a function of Vr, the craniospinal volume change due to respiration within each respiratory 
cycle, and k. Vp = 5 ml.  
 
Page 13 of 21 
 
To determine possible influences of zero-point and span errors in the ICP signal, we 
introduced such errors analytically in Equation 2, the definition of RAQ. The effect of a zero-
point calibration error, ez, is shown in Equation 6: With p1 the inspiratory minimum ICP and 
p2 the expiratory maximum, p1 the amplitude of the cardiac pulse wave in inspiration and 
p2 the amplitude of the cardiac pulse wave in expiration, we obtain 
 𝑅𝐴𝑄 = 𝑝2 + 𝑒𝑧 − 𝑝1− 𝑒𝑧
𝑝2+ 𝑒𝑧 − 𝑝1 − 𝑒𝑧 = 𝑝2− 𝑝1𝑝2−𝑝1 . (6) 
 
It is evident that the zero-point error does not affect RAQ, since the error terms in both the 
numerator and denominator add up to zero. Similarly, RAQ is not influenced by a span 
calibration error, es, as shown in Equation 7. This is because es scales numerator and 
denominator equally: 
 
 𝑅𝐴𝑄 = 𝑒𝑠 ∙ 𝑝2  − 𝑒𝑠 ∙ 𝑝1𝑒𝑠 ∙ 𝑝2− 𝑒𝑠 ∙ 𝑝1 = 𝑝2− 𝑝1𝑝2−𝑝1 (7) 
 
 
3.2 Analysis of synthetic ICP signals 
 
For the synthetic ICP time course shown as orange line in Fig. 5 (k=0.15), an RAQ value of 
1.349 was expected, while numerically we obtained 1.327 (Table 1). Similar results were seen 
for k=0.1 and k=0.125, as well as for the ICP signal with a step increase in mean value shown 
in Fig. 6. Taken together, these results indicate that our algorithm and its implementation are 
sound, and that RAQ is insensitive to step changes in ICP caused by exogenous factors.  
 
k [1/ml] Step [mmHg] RAQe  RAQcalc RAQe - RAQcalc Relative Error [%] 
         
0.100 0 2.011 1.971 0.040 1.99 
0.100 1 2.011 1.971 0.040 1.98 
0.100 2 2.011 1.971 0.040 1.99 
0.100 3 2.011 1.971 0.040 1.99 
0.125 0 1.613 1.585 0.028 1.75 
0.125 1 1.613 1.585 0.028 1.73 
0.125 2 1.613 1.586 0.028 1.72 
0.125 3 1.613 1.586 0.028 1.72 
0.150 0 1.349 1.327 0.023 1.67 
0.150 1 1.349 1.327 0.022 1.62 
0.150 2 1.349 1.328 0.021 1.59 
0.150 3 1.349 1.328 0.021 1.59 
            
        Mean 1.78 
 
Table 1. Comparison of expected (RAQe) and calculated (RAQcalc) values for three systems described by Eq. 3 
with k of 0.1, 0.125 and 0.15 ml-1 and steps of 1, 2, and 3 mmHg. RAQcalc values were determined numerically 
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3.3 Analysis of ICP measured in patients 
 
We found significantly different RAQB values in the two patient groups, namely 0.857 in 
AQS compared to 1.065 in NNPH, p = 0.027. In contrast, there was no significant difference 
between the respective RAQC values. For cases where lumbar infusion testing had been 
performed, we also calculated k, RO, and PVI, finding no significant difference between the 
two patient groups. Table 2 and Fig. 10 summarize these findings. Table 2 also contains the 
values ICPS, ICPSmean, and TFS, which quantify the B-waves and their occurrence, as well as 
heart rate (HR) and respiratory rate (RR). Tables 3 and 4 in Appendix II show the individual 
values for each patient.  
 
 Group  Parameter 
  ICP [mmHg] RAQB [-] PVI [ml] RO [mmHg / (ml / min)] k [1 / ml] Age [years] RR [1 / min] HR [1 /  min] RAQC  [-] ICPSmean  [mmHg] TFS [-] ICPS [mmHg] n [-] 
               
NNPH  5.76  ± 4.94 1.065 ± 0.195 16.08 ± 11.53 12.14 ± 6.39 0.206 ± 0.127 72.5 ± 6.1 15.1±0.7 65.6±15.6 1.38 ± 0.32 0.367±0.135 0.377±0.11 0.987±0.264 17 
AQS 8.96  ±  4.49 0.857  ± 0.109 18.26 ± 9.84 11.63 ± 5.38 0.232 ± 0.159 55.8 ± 18.0 15.0±0.6 60.9±14.1 1.20±0.21 0.785±0.290 0.572±0.12 1.337±0.240 6 
                            
p-value 0.31 0.027 0.621 0.823 0.983 0.015 0.860 0.462 0.220 0.001 0.013 0.025   
                            
Female 6.43  ± 4.52 1.001 ± 0.119 14.23 ± 4.69 10.51 ± 4.26 0.216 ± 0.118 69.2 ± 6.8 15.3 ± 0.8 63.3 ± 11.7 1.34 ± 0.18 0.426 ± 0.151 0.409 ± 0.112 1.028 ± 0.193 11 
Male 6.75  ± 5.45 1.020 ± 0.251 18.84 ± 14.36 13.35 ± 7.19 0.211 ± 0.151 67.2 ± 16.5 14.9 ± 0.5 65.3 ± 18.0 1.33 ± 0.39 0.521 ± 0.327 0.444 ± 0.166 1.124 ± 0.366 12 
                            
p-value 0.926 0.735 0.842 0.278 0.589 0.440 0.339 0.781 0.442 0.976 0.902 0.580   
 
Table 2. Differences in age, craniospinal pressure-volume parameter values, and B-wave parameters between 
the NNPH and AQS patient groups, as well as between female and male patients. P-values indicating a 
statistically significant difference are shown in bold numbers. With the exception of the sample size n and p-
values, numbers indicate mean ± standard deviation. The significance level was set at α=0.05.  
ICP: intracranial pressure; RAQB: mean RAQ during B-waves; PVI: pressure volume index; RO: outflow 
resistance; k: elastance coefficient; RR: respiratory rate; HR: heart rate; RAQC: mean RAQ during the recording; 
TFS: time fraction of recording containing B-waves; ICPS: root mean square amplitude of the B-waves, averaged 




Fig. 10. Mean RAQB and standard deviation for the NNPH and AQS patient groups. RAQB differs significantly 




We defined the new surrogate RAQ, respiratory amplitude quotient, as the ratio of the 
amplitude of the respiratory wave in the ICP signal to the amplitude of the respiration-induced 
wave in the course of the ICP cardiac pulse wave amplitude. We determined RAQ 
retrospectively in the ICP recordings of two groups of patients with different types of 
hydrocephalus. Comparing, between these two groups, the respiratory amplitude quotient  
averaged over the full recording time, RAQC, and over the B-wave containing periods, RAQB, 
as well as pressure volume index, resistance to outflow and elastance coefficient, we found 
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that only RAQB differed significantly (p = 0.027). Since RAQ may provide information for 
the discrimination of the two groups included in this study, its potential as a tool for 
stratification of patients with suspected space occupying pathologies should be further 
investigated. 
 
4.1 Resilience to errors and changes in ICP not caused by altered pressure-volume 
relationship 
 
Our results demonstrate that RAQ is resilient to certain types of errors in the assessed signal. 
As a quotient of amplitudes, RAQ is not affected by zero-point calibration errors of the ICP 
signal. It is also not influenced by span calibration errors, as these scale numerator and 
denominator of Equation (2) equally. Consequently, RAQ is also not affected by zero-point 
drifts as encountered in epidural pressure monitoring [22] and long-term telemetric 
monitoring [23]. However, linearity calibration errors are not inherently compensated and 
must still be considered. Also, we did not investigate the effect of other sources of disturbance 
and noise, such as line frequency noise, electromagnetic disturbances and vibrations. Future 
studies are needed to assess those.  
 
Next to errors in the ICP signal, another potential source of disturbance is the numerical 
implementation of RAQ. We found good agreement of RAQ values determined with the 
Matlab implementation compared to the theoretically expected values when analysing 
synthetically produced waveforms. The deviation was below 2% for all assessed cases, which 
is well acceptable for potential clinical applications.  
 
RAQ shows a level of resilience to changes in ICP that are not caused by an altered pressure-
volume relationship. A typical example of such ICP changes encountered in clinical practice 
are pressure steps or drops when the position of the patient is changed. Algorithms based on 
mean ICP and amplitude, such as the RAP described by Price et al. [15], are not resilient to 
positional changes in ICP.  
 
Taken together, RAQ shows promise as a potentially resilient surrogate for the pressure-
volume relationship that can be calculated from signals with span and/or zero-point 
calibration errors, including non-invasively obtained ICP time courses with unknown 
calibration constants.  
 
 
4.2 Underlying physiological assumptions 
 
We defined RAQ based on the assumption that during normal tidal respiration, ICP moves 
along the pressure-volume curve. In other words, the shape of the pressure-volume curve is 
presumed to be unaltered by the respiratory changes of ICP, and that, therefore, RAQ does not 
change during the respiratory cycle. Since this assumption is very difficult to verify, it 
constitutes currently one of the limitations of the new surrogate. 
 
Our results show that Vp, the transient craniospinal volume change during a cardiac cycle, 
has a strong influence on RAQ. Cerebral perfusion is relatively constant at 45 – 55 
ml/100g/min [24] and is kept constant by cerebral autoregulation. Consequently, an increase 
in heart rate should result in a decrease in Vp and vice versa. In our patient cohort, there was 
no significant difference in the mean heart rates between the two groups. For a given cerebral 
perfusion and heart rate, Vp will depend on brain size. In this retrospective study, we did not 
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have information on patients’ brain sizes or on other parameters based on which we could 
have estimated them.  
 
4.3 Interpretation and potential applications of RAQ 
 
RAQ reflects the exponential character of the pressure-volume relationship in regions I (high 
compliance, low ICP, high RAQ) and II (decreased compliance, increased ICP, lower RAQ) 
as shown in Fig. 11. In region III, where the cerebral compensatory reserve is impaired, the 
pressure-volume curve is characterized by a decreasing slope [18]. At the transition to this 
region, where V = Vkrit and p = pkrit (limit of impaired cerebral compensatory reserve), the 
curvature changes from convex to concave. RAQ tends to infinity as this point is approached. 
V/p increases with increasing V in region III, and RAQ is negative. This is evident in 
Equation 8, where p1 is the inspiratory minimum ICP and p2 the expiratory maximum, p1 the 
amplitude of the cardiac pulse wave in inspiration and p2 the amplitude of the cardiac pulse 
wave in expiration: 
 
 𝑅𝐴𝑄 = 𝑝2 − 𝑝1
𝑝2 − 𝑝1   (8) 
 
In region III, p2 is smaller than p1. The denominator of the equation is thus negative, while 
the numerator is positive and, therefore, RAQ is negative. p2 is equal to p1 at the transition 
between regions II and III. As the denominator tends to zero, the quotient tends to infinity. 
 
 
Fig. 11. Generic representation of three characteristic regions of the craniospinal pressure-volume curve. Region 
I: Characterized by comparably small cardiac pulse wave amplitudes. Region II: Exponential relationship as in 
the first region, but characterized by fast increase in cardiac pulse wave amplitudes with increasing craniospinal 
volume. Region III: Diminishing cardiac pulse wave amplitudes. For lack of an established quantitative 
description in humans, a logarithmic relationship is used here for illustrative purposes. 
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Before a potential clinical use as a surrogate for the pressure-volume relationship can be 
targeted, RAQ may be of value for pathophysiological investigations. For instance, B-waves 
are a sign of reduced craniospinal compliance in hydrocephalus patients. The fact that our 
AQS-patients had increased B-waves (as quantified by ICPS) and, at the same time, reduced 
RAQ during B-waves (as quantified by RAQB), could indicate that not only compliance is 
reduced during periods of B-waves, but also that the pressure-volume relationship is altered. 
Furthermore, the shift from positive values of RAQ to negative ones in the transition between 
regions II and III could serve as an indicator for impaired cerebral compensatory reserve.  
 
4.4 Limitations  
 
The main limitations of the methodology for calculating RAQ are the assumptions that Vp is 
constant, and that RAQ does not change during each cardiac cycle, respiratory cycle and over 
the observation period. While we have shown that RAQ possesses a level of resilience to 
some measurement errors and to changes in ICP that are not caused by an altered pressure-
volume relationship, we did not perform an exhaustive investigation of the effects of other 
disturbances and noise. Care must be taken when using RAQ in the transition to impaired 
cerebral compensatory reserve, where the slope of the pressure-volume curve shifts from 
positive to negative, and RAQ tends to infinity. 
 
The clinical arm of our study is limited by the fact that no invasive ICP data could be obtained 
from healthy subjects serving as a control group. Therefore, we did not compare impaired to 
normal CSF circulation cases, but impaired (AQS) to possibly not impaired ones (NNPH). 
The former group included a relatively low number of patients, and the two groups were not 
age and sex matched. The study’s primary technical shortcoming is the low ICP sampling rate 
of 50 Hz. The sampling rate needs to be sufficiently high to capture high frequency 
components that may contribute to signal peaks used in the derivation of RAQ. Currently, we 
do not have data to assess the influence of the sampling rate on the calculation of RAQ in ICP 




RAQ is a new surrogate for the craniospinal pressure-volume relationship. Since it can be 
calculated directly from ICP signals, it does not require volume loading and, therefore, has a 
lower degree of invasiveness and carries a lower risk of infections. Furthermore, alterations of 
ICP introduced by changes in body position that do not affect the pressure-volume 
relationship, as well as span and zero-point calibration errors are not reflected in RAQ. 
 
Once RAQ is better understood, it might prove useful for the characterization of space 
occupying pathologies such as traumatic brain injury, tumors, postoperative swelling and 
hydrocephalus. Until then, observations made in the current investigation need to be 
confirmed in prospective studies. Further research is required to characterize both 
physiological and exogenous factors that may affect RAQ without influencing the pressure-
volume relationship. These include the inter- and intra-patient variability of the craniospinal 
volume change due to cardiac action within each cardiac cycle, possible change of the 
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program determineRAQ  
 
// functions minimax(ICP[],i) and maximin(ICP[],i) return "true" if ICP[i] are recognized as minimum or maximum, respectively 
// minimax and maximin can make use of the AMPD algorithm or a zero crossing technique 
 
// function target[1:n]= transfer(source[],pointer,n) transfers n samples from the ring-memory source[] into target[1:n]  
// pointer points to the oldest sample 
 
// initialize variables 
 
fsample=100  // sample rate for ICP 
fsampleampmean=4 // sample rate for the ICPamps and ICPmeans time series 
 
i25=0   // counts to 25 to determine 250 ms intervals for the ICPamps and ICPmeans 
time series 
pointer=1  // pointer into ICPmeans[] and ICPamps[] 
pointercounter // counts 4 entries into the means and amps time series 
sumRAQ=0  // cumulated RAQ values 
countRAQ=0  // counter for cumulated RAQ values 
fl=10/60  // 0.1666 Hz, 10 per minute, lower limit for respiration frequency 
fu=20/60  // 0.3333 Hz, 20 per minute, upper limit for respiration frequency 
 
// the following limit indices might have to be adjusted to the respective FFT function 
// depending on how the FFT function arranges the resulting complex numbers 
// also the calculation of magnitudes might have to be adjusted 
 
l=7    // index for 0.1875 Hz line in the amplitude spectrum to approximate fl 
u=11   // index for 0.3125 Hz line in the amplitude spectrum to approximate fu 
 
ii=0   // the running index into ICP[] 
 





mmin=false  // marker minimum found 
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 if minimax(ICP[],ii) // diastolic minimum identified? 
   
  ICPmin=ICP[ii] 
  imin=ii 




// the main loop 
 
for ii=iibegin to iend // go through the time series sampled at 100 Hz 
 
 if (mmin) // search for maximum 
  if maximin(ICP[],ii) // systolic maximum identified? 
   ICPmax=ICP[ii] 
   imax=ii 
   ICPamp=ICPmax-ICPmin 
   ICPmean=mean(ICP[imin:imax]) 
   mmin=false 
 if (min==false) 
  if minimax(ICP[],ii) // diastolic minimum identified? 
   ICPmin=ICP[ii] 
   imin=ii 
   ICPamp=ICPmax-ICPmin 
   ICPmean=mean(ICP[imax:imin]) 
   mmin=true 
 
 i25++    // 250 ms ? 
 
 if (i25==26) // yes 
  i25=1 
  ICPmeans[pointer]=ICPmean // enter mean and amp into the respective time series 
  ICPamps[pointer]=ICPamp 
  pointer++ 
 
  if pointer>64 
   pointer=1 
 
  pointercounter++ 
  if (pointercounter==5) // 1 second? 
   pointercounter=1 
 
// calculate RAQ 
 
   fftinput[1:64]=transfer (ICPmeans[],pointer,64)  // transfer the time series in ICPmeans to fftinput[]  
   fftinput[1:64]=fftinput[1:64]-mean(fftinput[1:64]) // remove offset 
   fftinput[65:128]=0 // pad with zeroes 
   fftoutput[] = fft(fftinput[],128)    // 128 point fft returns complex spectral lines 
   magnitudes[l:u]=abs(fftoutput[l:u])   // the magnitudes calculated from the complex spectral  
      // lines in the respiratory frequency range 
   Arp=mean(magnitudes[l:u])   // highest spectral line in the respiratory frequency  
      // range 
 
   fftinput[1:64]=transfer (ICPamps[],pointer,64)  // transfer the time series in ICPamps to fftinput[]  
   fftinput[1:64]=fftinput[1:64]-mean(fftinput[1:64]) // remove offset 
   fftinput[65:128]=0    // pad with zeroes 
   fftoutput[]=fft(fftinput[],128)    // 128 point fft returns complex spectral lines 
   magnitudes[l:u]=abs(fftoutput[l:u])   // the magnitudes calculated from the complex spectral  
      // lines in the respiratory frequency range 
   AAvp=mean(magnitudes[l:u])   // highest spectral line in the respiratory  
      // frequency range 
 
   RAQ=Arp/AAvp 
 
   sumRAQ=sumRAQ+RAQ 
   countRAQ++ 
next ii 
 














Table 3. Values of craniospinal pressure-volume parameters and age for individual patients in the NNPH group 
 
 
AQ                          
                           
Pat. Nr. Age [years] sex ICP [mmHg] RR [1/min] HR [1/min] RAQB RAQC ICPSmean [mmHg] TFS ICPS [mmHg] PVI [ml] RO [mmHg/(ml/min)] k [1/ml] 
                           
105 63 f 12.41 14.7 53.5 0.911 1.093 0.546 0.502 1.088 6.55 6.79 0.35 
54 53 m 14.31 15.3 55.0 0.804 1.070 1.041 0.715 1.455 33.83 7.49 0.07 
47 64 m 1.51 14.3 41.7 0.650 1.073 1.297 0.720 1.800 25.05 8.01 0.09 
43 63 f 6.66 15.5 75.0 0.980 1.556 0.558 0.419 1.331 11.93 20.35 0.48 
60 74 m 6.33 15.8 83.5 0.947 1.432 0.530 0.461 1.148 13.95 15.51 0.17 
57 18 m 12.55 14.4 56.4 0.851 1.021 0.737 0.614 1.200       
 




NNPH                          
                           
Pat. Nr. Age [years] sex ICP [mmHg] RR [1/min] HR [1/min] RAQB RAQC ICPSmean [mmHg] TFS ICPS [mmHg] PVI [ml] RO [mmHg/(ml/min)] k [1/ml] 
                           
75 68 f 9.11 16.6 70.8 1.075 1.479 0.488 0.394 1.240 11.66 12.40 0.20 
114 77 m 5.35 14.5 98.4 0.957 0.873 0.265 0.533 0.498 19.63 32.96 0.10 
51 77 m 6.91 15.3 65.7 1.472 1.943 0.462 0.296 1.564       
81 73 f 3.03 14.6 69.0 0.845 1.173 0.441 0.510 0.864 14.32 7.76 0.16 
63 72 f 8.94 15.8 58.4 1.138 1.210 0.132 0.139 0.952 20.75 14.53 0.11 
125 83 m 9.68 15.3 70.0 0.975 2.002 0.416 0.310 1.344 5.59 14.17 0.41 
49 72 f 8.57 15.2 76.5 0.886 1.518 0.457 0.488 0.937 19.48 7.33 0.12 
32 76 m 12.59 14.4 83.0 0.885 1.176 0.389 0.510 0.763 16.40 10.76 0.14 
55 83 f 2.55 16.7 71.5 1.212 1.643 0.217 0.345 0.629       
87 58 f -3.41 14.9 34.9 1.075 1.349 0.452 0.457 0.990       
94 69 m 8.29 14.7 60.6 1.239 1.635 0.155 0.224 0.693 52.90 15.78 0.04 
37 72 m 6.34 15.0 69.7 1.502 1.711 0.298 0.314 0.950 9.62 10.80 0.24 
110 73 m -6.78 15.4 28.9 1.088 1.052 0.418 0.356 1.176 6.84 10.85 0.34 
10 70 f 10.77 15.1 63.9 0.827 1.171 0.693 0.564 1.229 20.16 7.13 0.11 
61 70 m 3.90 14.7 71.1 0.866 0.911 0.248 0.278 0.892 4.54 7.17 0.51 
99 76 f 2.28 15.0 68.3 1.067 1.356 0.380 0.331 1.148 13.71 9.55 0.17 
100 63 f 9.78 14.1 54.0 0.998 1.213 0.322 0.355 0.905 9.52 8.78 0.24 
